What the FDA labels say about taking them together
Heparin and ticagrelor
Ticagrelor's FDA label of May 7, 2026 names heparin in its warnings and precautions section; the heparin labels PlainMeds reads (4) do not name ticagrelor.
Check it at the source: the heparin FDA label on DailyMed (effective November 28, 2025, Fresenius Kabi USA, LLC); the ticagrelor FDA label on DailyMed (effective May 7, 2026, AstraZeneca Pharmaceuticals LP).
What does the heparin label say about ticagrelor?
Heparin's label (effective November 28, 2025) and its 3 other brand-application labels do not name ticagrelor in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Heparin Sodium), Fresenius Kabi USA, LLC, effective November 28, 2025 (SPL set d55b4a63-0c04-4874-b74f-9e9b9e8b008c), via openFDA; the full label on DailyMed
What does the ticagrelor label say about heparin?
Ticagrelor label, warnings and precautionsLaboratory Test Interference: False negative platelet functional test results have been reported for Heparin Induced Thrombocytopenia (HIT).
Source: FDA drug label (BRILINTA), AstraZeneca Pharmaceuticals LP, effective May 7, 2026 (SPL set f7b3f443-e83d-4bf2-0e96-023448fed9a8), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Heparin | Ticagrelor | |
|---|---|---|
| Labeled for | Blood clots (DVT and PE), Atrial fibrillation | Heart attack and coronary artery disease, Stroke prevention |
| Boxed warning | No | Yes |
| Pharmacy cost (NADAC) | $1.18 per mL 5,000 unit/mL vial | $0.253 per tablet 90 mg tablet |
| Shortage now | In shortage | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once